NCT07385079 2026-02-03
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Not yet recruiting
Clinical Trials
12 trialsNCT07373990 2026-01-28
Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Not yet recruiting
NCT05305131 2025-09-23
Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
National University Hospital, Singapore
Phase 2 Recruiting
NCT06802835 2025-05-16
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 1/2 Recruiting
NCT05587374 2025-01-23
GEMSTONE
Sun Yat-sen University
Phase 3 Active not recruiting
NCT03840421 2025-01-13
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Active not recruiting
NCT06611826 2024-09-25
GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC
Zhejiang Cancer Hospital
Phase 2 Not yet recruiting
NCT06019130 2024-05-16
NPC-Nivo
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase 2 Recruiting
NCT00370890 2022-02-17
A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Chinese University of Hong Kong
Phase 3 Completed
NCT01528618 2021-10-04
Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Completed
NCT02627807 2020-06-16
Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase NA Unknown
NCT03619824 2018-10-09
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown